Glyburide
42 NDCs across 6 manufacturers|42 Generic,0 Brand
Glyburide is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on May 1, 1984, and the first generic was approved Aug 29, 1995. FDA's Orange Book lists 24 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $3 million on Glyburide across 196,000 claims for 58,000 beneficiaries.
Glyburide is available as 42 NDCs from 6 manufacturers (42 generic, 0 brand), with NADAC prices from $0.06 to $0.24 per EA — the most expensive product costs about 4.3× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
42
42G / 0B
Manufacturers
6
competing in market
Price Spread
$0.06 – $0.24
per EA
7d Activity
avg -3.5% WoW · of 42 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Teva Pharmaceuticals USA Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Sulfonylurea class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
6 manufacturers producing GLYBURIDE
Frequently Asked Questions
What is Glyburide used to treat?
Glyburide is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.
When did Glyburide become available as a generic?
FDA approved the first generic Glyburide (ANDA) on Aug 29, 1995. The Orange Book currently lists 24 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Glyburide?
In 2024, Medicare Part D spent $3 million on Glyburide across 196,000 claims for 58,000 beneficiaries.
How many Glyburide products are on the market?
The Glyburide drug market contains 42 NDCs from 6 manufacturers — 42 generic and 0 brand products.
What is the price range for Glyburide?
NADAC reference prices for Glyburide range from $0.0555 to $0.2394 per EA — the most expensive product costs about 4.3× the cheapest.
Which manufacturers make Glyburide?
6 manufacturers list Glyburide in NADAC. Ranked by number of NDCs, the largest are Teva Pharmaceuticals USA Inc. (19), Modavar Pharmaceuticals LLC (7), Zydus Pharmaceuticals (USA) Inc. (5), Nivagen Pharmaceuticals Inc. (4), Heritage Pharmaceuticals Inc. (4).
How has the price of Glyburide changed recently?
Over the past 7 days, 12 Glyburide NDCs rose and 15 fell, with a market-wide average change of -3.5%.